These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28098757)

  • 1. Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis.
    Bianchi E; Ruberti S; Rontauroli S; Guglielmelli P; Salati S; Rossi C; Zini R; Tagliafico E; Vannucchi AM; Manfredini R
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF.
    Bianchi E; Bulgarelli J; Ruberti S; Rontauroli S; Sacchi G; Norfo R; Pennucci V; Zini R; Salati S; Prudente Z; Ferrari S; Manfredini R
    Cell Death Differ; 2015 Dec; 22(12):1906-21. PubMed ID: 25857263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients.
    Ruberti S; Bianchi E; Guglielmelli P; Rontauroli S; Barbieri G; Tavernari L; Fanelli T; Norfo R; Pennucci V; Fattori GC; Mannarelli C; Bartalucci N; Mora B; Elli L; Avanzini MA; Rossi C; Salmoiraghi S; Zini R; Salati S; Prudente Z; Rosti V; Passamonti F; Rambaldi A; Ferrari S; Tagliafico E; Vannucchi AM; Manfredini R
    Leukemia; 2018 Feb; 32(2):438-449. PubMed ID: 28745329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6.
    Rontauroli S; Norfo R; Pennucci V; Zini R; Ruberti S; Bianchi E; Salati S; Prudente Z; Rossi C; Rosti V; Guglielmelli P; Barosi G; Vannucchi A; Tagliafico E; Manfredini R
    Oncotarget; 2017 Mar; 8(13):21380-21397. PubMed ID: 28423484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis.
    Norfo R; Zini R; Pennucci V; Bianchi E; Salati S; Guglielmelli P; Bogani C; Fanelli T; Mannarelli C; Rosti V; Pietra D; Salmoiraghi S; Bisognin A; Ruberti S; Rontauroli S; Sacchi G; Prudente Z; Barosi G; Cazzola M; Rambaldi A; Bortoluzzi S; Ferrari S; Tagliafico E; Vannucchi AM; Manfredini R;
    Blood; 2014 Sep; 124(13):e21-32. PubMed ID: 25097177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis.
    Rossi C; Zini R; Rontauroli S; Ruberti S; Prudente Z; Barbieri G; Bianchi E; Salati S; Genovese E; Bartalucci N; Guglielmelli P; Tagliafico E; Rosti V; Barosi G; Vannucchi AM; Manfredini R;
    Mol Oncol; 2018 Dec; 12(12):2102-2123. PubMed ID: 30259659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1.
    Zini R; Rossi C; Norfo R; Pennucci V; Barbieri G; Ruberti S; Rontauroli S; Salati S; Bianchi E; Manfredini R
    Stem Cells Dev; 2016 Oct; 25(19):1433-43. PubMed ID: 27520398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells.
    Guglielmelli P; Bisognin A; Saccoman C; Mannarelli C; Coppe A; Vannucchi AM; Bortoluzzi S
    PLoS One; 2015; 10(10):e0140445. PubMed ID: 26468945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
    Manshouri T; Verstovsek S; Harris DM; Veletic I; Zhang X; Post SM; Bueso-Ramos CE; Estrov Z
    PLoS One; 2019; 14(9):e0222912. PubMed ID: 31569199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19
    Qu M; Fang F; Zou X; Zeng Q; Fan Z; Chen L; Yue W; Xie X; Pei X
    Cell Death Dis; 2016 Oct; 7(10):e2430. PubMed ID: 27763644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.
    Wang X; Haylock D; Hu CS; Kowalczyk W; Jiang T; Qiu J; Mosoyan G; He W; Marshall N; Mascarenhas J; Tarasova A; Brody J; Winkler D; Hoffman R
    Blood; 2016 Jun; 127(26):3398-409. PubMed ID: 27114459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-199a-5p inhibits monocyte/macrophage differentiation by targeting the activin A type 1B receptor gene and finally reducing C/EBPα expression.
    Lin HS; Gong JN; Su R; Chen MT; Song L; Shen C; Wang F; Ma YN; Zhao HL; Yu J; Li WW; Huang LX; Xu XH; Zhang JW
    J Leukoc Biol; 2014 Dec; 96(6):1023-35. PubMed ID: 25258381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis.
    Desterke C; Bilhou-Nabéra C; Guerton B; Martinaud C; Tonetti C; Clay D; Guglielmelli P; Vannucchi A; Bordessoule D; Hasselbalch H; Dupriez B; Benzoubir N; Bourgeade MF; Pierre-Louis O; Lazar V; Vainchenker W; Bennaceur-Griscelli A; Gisslinger H; Giraudier S; Le Bousse-Kerdilès MC; ; ;
    Cancer Res; 2011 Apr; 71(8):2901-15. PubMed ID: 21487043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophages.
    Rodriguez-Ubreva J; Ciudad L; van Oevelen C; Parra M; Graf T; Ballestar E
    Mol Cell Biol; 2014 Mar; 34(6):1145-57. PubMed ID: 24421386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53.
    Navarro F; Gutman D; Meire E; Cáceres M; Rigoutsos I; Bentwich Z; Lieberman J
    Blood; 2009 Sep; 114(10):2181-92. PubMed ID: 19584398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.
    Wang X; Zhang W; Tripodi J; Lu M; Xu M; Najfeld V; Li Y; Hoffman R
    Blood; 2010 Dec; 116(26):5972-82. PubMed ID: 20858855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells.
    Calura E; Pizzini S; Bisognin A; Coppe A; Sales G; Gaffo E; Fanelli T; Mannarelli C; Zini R; Norfo R; Pennucci V; Manfredini R; Romualdi C; Guglielmelli P; Vannucchi AM; Bortoluzzi S
    Blood Cancer J; 2016 Jun; 6(6):e439. PubMed ID: 27341078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.
    Liang J; Li Y; Daniels G; Sfanos K; De Marzo A; Wei J; Li X; Chen W; Wang J; Zhong X; Melamed J; Zhao J; Lee P
    Mol Cancer Res; 2015 Apr; 13(4):681-8. PubMed ID: 25587085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-34a-5p promotes autophagy and apoptosis of ovarian granulosa cells via the Hippo-YAP signaling pathway by targeting LEF1 in chicken.
    Han S; Zhao X; Zhang Y; Amevor FK; Tan B; Ma M; Kang H; Wang J; Zhu Q; Yin H; Cui C
    Poult Sci; 2023 Feb; 102(2):102374. PubMed ID: 36529101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.